…
Nufarm Limited, together with its subsidiaries, develops, manufactures, and sells crop protection solutions and seed technologies in Europe, the Middle East, Africa, North America, and the Asia Pacific. The company operates through Crop Protection and Seed Technologies segments. The company offers herbicides, insecticides, and fungicides that help growers protect crops against weeds, pests, and diseases. It also operates base seeds, bioenergy, omega-3 and seed treatment platforms, as well as sells seeds and oil-based products. It also focuses on crops, such as cereals; corn; soybean; pasture, turf, and ornamentals; and trees, nuts, vines, and vegetables. In addition, the company provides seed treatment products for the protection and treatment of damage caused by insects, fungus, and disease. Further, it distributes sunflower, sorghum, carinata, energy cane and canola seeds. The company was founded in 1916 and is headquartered in Laverton North, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Nufarm Limited is an agricultural chemical company that develops, manufactures and sells crop protection products and seed treatments to growers across broadacre and specialty crops worldwide. Its long-term growth may be supported by rising demand for higher crop yields, expansion in emerging markets and product innovation in herbicides, fungicides and seed technologies. The company’s global manufacturing footprint and distribution network appears positioned to benefit from scale and recurring demand.
Investors should monitor regulatory restrictions on active ingredients, weather-driven agricultural volatility, competitive and pricing pressure from larger agrochemical multinationals, currency exposure and execution risks around product approvals and supply-chain reliability.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2023-07-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2023-07-31 | 2022-09-30 |
| Income before tax | -175.30M | -45.26M | 154.83M | 154.83M | 128.10M |
| Net income | -109.28M | -5.60M | 111.14M | 111.14M | 107.44M |
| Selling general administrative | 246.87M | 197.58M | 230.56M | 746.14M | 198.81M |
| Selling and marketing expenses | 661.86M | 550.78M | 515.59M | - | 523.34M |
| Gross profit | 899.99M | 840.37M | 1026.37M | 1026.37M | 972.59M |
| Reconciled depreciation | 221.97M | 212.19M | 188.37M | 188.37M | 213.68M |
| Ebit | -42.04M | 51.59M | 236.26M | - | 203.16M |
| Ebitda | 104.68M | 263.77M | 424.63M | - | 416.84M |
| Depreciation and amortization | 146.73M | 212.19M | 188.37M | - | 213.68M |
| Operating income | -300.03M | -174.66M | 236.26M | 47.17M | 203.16M |
| Other operating expenses | 3743.41M | 3520.57M | 3433.44M | - | 3787.32M |
| Interest expense | 92.02M | 105.25M | 81.43M | 81.43M | 75.06M |
| Tax provision | -9.98M | -39.66M | 43.69M | 43.69M | 20.66M |
| Interest income | 6.72M | 6.50M | 5.38M | 5.38M | 2.38M |
| Net interest income | -94.95M | -98.75M | -84.58M | -84.58M | -80.18M |
| Income tax expense | -9.98M | -39.66M | 43.69M | - | 20.66M |
| Total revenue | 3443.38M | 3345.91M | 3480.61M | 3480.61M | 3772.97M |
| Total operating expenses | 1200.01M | 1015.03M | 979.20M | - | 986.94M |
| Cost of revenue | 2543.39M | 2505.54M | 2454.24M | 2454.24M | 2800.39M |
| Total other income expense net | 124.72M | 129.40M | 3.85M | 3.85M | 8.96M |
| Net income from continuing ops | -165.32M | -5.60M | 111.14M | 111.14M | 107.44M |
| Net income applicable to common shares | - | - | - | - | 99.92M |
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2023-07-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2023-07-31 | 2022-09-30 |
| Total assets | 3030.56M | 4427.41M | 4625.07M | 4625.07M | 4659.10M |
| Intangible assets | 627.71M | 982.44M | 1006.52M | 1006.52M | 977.06M |
| Other current assets | -376.09M | 51.59M | 75.41M | - | 74.70M |
| Total liab | 1635.49M | 2216.24M | 2315.18M | 2315.18M | 2506.38M |
| Total stockholder equity | 1395.07M | 2211.17M | 2309.89M | 2309.89M | 2152.72M |
| Deferred long term liab | - | - | - | - | 405.90M |
| Other current liab | -218.12M | 174.34M | -628.76M | - | -1095.65M |
| Common stock | 1223.29M | 1847.86M | 1840.61M | - | 1837.23M |
| Capital stock | 1850.61M | 1847.86M | 1840.61M | 1840.61M | 1837.23M |
| Retained earnings | -98.62M | 30.95M | 89.34M | 89.34M | 25.81M |
| Other liab | - | - | - | - | 236.25M |
| Good will | 150.22M | 216.54M | 223.73M | 223.73M | 215.72M |
| Other assets | - | - | - | - | 574.48M |
| Cash | 313.80M | 463.56M | 410.96M | 410.96M | 585.70M |
| Total current liabilities | 826.80M | 1023.67M | 872.99M | 872.99M | 1607.43M |
| Current deferred revenue | - | - | 91.51M | - | 128.24M |
| Net debt | 544.81M | 634.76M | 849.84M | 705.17M | 346.17M |
| Short term debt | 265.13M | 82.01M | 47.76M | - | 269.17M |
| Short long term debt | 244.24M | 63.49M | 29.04M | 29.04M | 250.59M |
| Short long term debt total | 1298.92M | 1098.32M | 1260.80M | - | 931.87M |
| Other stockholder equity | - | - | 246.93M | - | 246.93M |
| Property plant equipment | - | - | - | - | 475.33M |
| Total current assets | 1513.35M | 2312.69M | 2574.45M | 2574.45M | 2761.10M |
| Long term investments | 72.81M | 63.67M | 68.33M | 68.33M | 61.31M |
| Net tangible assets | - | - | - | - | 1118.91M |
| Net receivables | 400.34M | 631.53M | 624.07M | 530.42M | 498.24M |
| Long term debt | 902.54M | 887.86M | 1087.09M | 1087.09M | 539.41M |
| Inventory | 1175.30M | 1166.01M | 1464.01M | 1464.01M | 1602.46M |
| Accounts payable | 779.79M | 767.32M | 673.36M | 673.36M | 1147.45M |
| Accumulated other comprehensive income | 107.17M | 85.43M | 133.01M | - | 42.75M |
| Non currrent assets other | -303.35M | 16.23M | 6.44M | - | 3.78M |
| Non current assets total | 1517.21M | 2114.73M | 2050.61M | 2050.61M | 1898.00M |
| Capital lease obligations | 152.13M | 146.97M | 144.68M | 144.68M | 141.86M |
| Breakdown | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2023-07-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2023-07-31 | 2022-09-30 |
| Investments | -7.84M | -207.46M | -241.73M | -241.73M | -46.17M |
| Change to liabilities | - | - | - | - | 390.55M |
| Total cashflows from investing activities | -162.36M | -207.46M | -241.73M | - | -240.41M |
| Net borrowings | 133.57M | -124.02M | 287.64M | - | -190.87M |
| Total cash from financing activities | 55.44M | -200.76M | 185.98M | 185.98M | -264.37M |
| Change to operating activities | - | - | - | - | 8.85M |
| Net income | -109.28M | -3.87M | 111.14M | 111.14M | 107.44M |
| Change in cash | -6.71M | 52.61M | -174.75M | -181.37M | -138.51M |
| Begin period cash flow | 320.51M | 410.96M | 585.70M | 585.70M | 724.22M |
| End period cash flow | 313.80M | 463.56M | 410.96M | 410.96M | 585.70M |
| Total cash from operating activities | 107.59M | 472.39M | -125.62M | - | 359.57M |
| Depreciation | 146.73M | 146.71M | 188.37M | - | 139.55M |
| Other cashflows from investing activities | -32.93M | -79.45M | -96.57M | - | -84.47M |
| Dividends paid | 21.66M | 53.28M | 56.45M | -56.45M | 40.16M |
| Change to inventory | -75.96M | 296.79M | 130.61M | - | -684.57M |
| Change to account receivables | 20.66M | -3.68M | -123.19M | - | 259.52M |
| Other cashflows from financing activities | -56.47M | -22.27M | 832.55M | - | 444.44M |
| Change to netincome | - | - | - | - | 64.10M |
| Capital expenditures | 238.36M | 252.96M | 226.74M | 226.74M | 160.92M |
| Change in working capital | -10.22M | 318.46M | -464.65M | - | -25.65M |
| Stock based compensation | - | 6.28M | 5.85M | - | 4.61M |
| Other non cash items | 117.81M | 147.65M | 39.52M | - | 64.10M |
| Free cash flow | -75.60M | 219.43M | -352.36M | -352.36M | -160.92M |
Sector: Basic Materials Industry: Agricultural Inputs
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| NUFMF Nufarm Limited |
- -% |
2.00 | - | 15.77 | 0.26 | 0.66 | 0.73 | 15.55 |
| CTA-PB E. I. du Pont de Nemours and Company |
- -% |
56.02 | - | - | 3.43 | - | - | - |
| CTVA Corteva Inc |
0.17 1.48% |
11.64 | 49.93 | 19.65 | 3.12 | 2.19 | 3.23 | 19.19 |
| CTA-PA E. I. du Pont de Nemours and Company |
0.43 0.95% |
45.85 | - | - | 2.71 | - | - | - |
| NTR Nutrien Ltd |
0.94 1.37% |
69.42 | 15.94 | 14.90 | 1.38 | 1.42 | 1.72 | 7.72 |
Nufarm Limited, together with its subsidiaries, develops, manufactures, and sells crop protection solutions and seed technologies in Europe, the Middle East, Africa, North America, and the Asia Pacific. The company operates through Crop Protection and Seed Technologies segments. The company offers herbicides, insecticides, and fungicides that help growers protect crops against weeds, pests, and diseases. It also operates base seeds, bioenergy, omega-3 and seed treatment platforms, as well as sells seeds and oil-based products. It also focuses on crops, such as cereals; corn; soybean; pasture, turf, and ornamentals; and trees, nuts, vines, and vegetables. In addition, the company provides seed treatment products for the protection and treatment of damage caused by insects, fungus, and disease. Further, it distributes sunflower, sorghum, carinata, energy cane and canola seeds. The company was founded in 1916 and is headquartered in Laverton North, Australia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Gregory Allan Hunt AICD, AMP Harvard, Grad. Dip., Mgmnt, REBA | MD, CEO & Exec. Director | 1959 |
| Mr. Paul Ronald Townsend | Chief Financial Officer | 1966 |
| Mr. David Craig Allen | Group Exec. of Supply Chain Operations | NA |
| Ms. Rachel Scully | Gen. Mang. of Investor Relations & External Communications | NA |
| Ms. Kate Hall B.Sc., L.L.B., L.L.M. | Company Sec. & Group Gen. Counsel | NA |
| Mr. John Holding | Group Exec. of People & Performance | NA |
| Mr. Brent Zacharias | Group Exec. of Nuseed | NA |
| Mr. Rico Toft Christensen | Group Exec. of Portfolio Solutions | 1970 |
| Mr. Brendan M. Ryan B.B.A., F.C.A. | Chief Financial Officer | NA |
| Mr. David Craig Allen | Group Executive of Supply Chain Operations | 1961 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.